SCHEMBL13624017

SCHEMBL13624017

O=C1C=CN(CC(=O)c2ccccc2)C(C2CCCCC2)C1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GSK3A P49840 2/20 0.38
GSK3B P49841 2/20 0.38
NPC1 O15118 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
HSD11B1 P28845 3/20 0.37
HSD17B1 P14061 1/20 0.37
CHRM3 P20309 1/20 0.37
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13623996 0.78 P2RX7 (0.45) KMT2AALDH1A1KDM4EMEN1HPGD
SCHEMBL10200297 0.78 ALDH1A1 (0.42) KMT2AALDH1A1RAB9ASMN1; SMN2GSK3A
SCHEMBL13624018 0.77 PIK3CD (0.45) ALDH1A1HPGDRAB9ASMN1; SMN2GSK3A
SCHEMBL13624015 0.70 ALDH1A1 (0.36) KMT2AALDH1A1GSK3AGSK3B
SCHEMBL13624040 0.68 GRIN2B (0.48) KMT2AMEN1RAB9ANPC1HSD11B1
SCHEMBL13624010 0.67 P2RX7 (0.39) KMT2AALDH1A1MEN1TDP1GAA
SCHEMBL13624016 0.66 P2RX7 (0.43) KMT2AALDH1A1KDM4EMEN1HPGD
SCHEMBL20861305 0.64 PDE4A (0.48) KMT2AALDH1A1KDM4EMEN1HPGD
SCHEMBL11019763 0.64 HSD11B1 (0.67) KDM4EHPGDTDP1RAB9ASMN1; SMN2
SCHEMBL10895329 0.64 HSD11B1 (0.67) KDM4EHPGDTDP1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622489-B2 Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl)-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-dihydro-1N-pyrrol-1-carboxamide MERCK & CO., INC. (US) 2009-11-24 US disclosed